Photo of Nadia de la Houssaye

Nadia de la Houssaye can be reached at or 337.593.7634.

The ongoing coronavirus pandemic has pushed telehealth and mHealth to center stage as healthcare providers of all sizes look to provide care on virtual platforms. But the emergency – and the legislative and policy measures enacted to deal with it – won’t last forever. Nadia de la Houssaye contributed to a mHeathIntelligence roundup of experts

For a number of clear and compelling reasons, telemedicine (also known as telehealth) is rapidly becoming one of the most powerful weapons in the fight against the global coronavirus outbreak and COVID-19, the disease it causes. Telemedicine can reduce the need for in-person or in-hospital visits and, in turn, slow the transmission of the coronavirus among actual or potential patients by reducing the risk of contact with someone carrying the virus. Telemedicine helps protect providers from infection; reduces overall demands for increasingly scarce supplies, equipment, and human resources in a healthcare system already being pushed to its limits; and supports the dissemination of much-needed information regarding the pandemic to epidemiologists, researchers, and government entities.

The immediate benefits of telemedicine have received near-universal recognition. However, the value of telemedicine in the long term must also be recognized. While the COVID-19 emergency is an unwelcome laboratory in which to test this potential, our current situation provides an opportunity to learn more about how telemedicine can function most effectively, and helps us plan for its expanded use to improve the delivery of healthcare services long after this crisis has passed.Continue Reading Telemedicine and COVID-19: Immediate and Necessary Solutions, Long-Term Opportunities